Wockhardt partners with RDIF to produce and supply Sputnik vaccines

The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund), and Wockhardt, a global pharmaceutical company headquartered in India, have partnered to produce and supply Sputnik V and Sputnik Light vaccines against COVID-19.

The agreement was reached under the aegis of Enso Healthcare (part of Enso Group), RDIF's coordination partner for sourcing Sputnik V vaccines in India.

Powered by Capital Market - Live News